K. Gorelick
发表
S. Schreiber,
R. Clare,
G. D'Haens,
2017,
Gut.
K. Gorelick,
1998,
JAMA.
K. Gorelick,
2005,
The New England journal of medicine.
Chad W. Euler,
V. Fischetti,
M. Collin,
2010,
Antimicrobial Agents and Chemotherapy.
P. Barie,
S. Opal,
J. Vincent,
2019,
JAMA.
S. Vermeire,
J. S. Kim,
W. Sandborn,
2021,
Journal of Crohn's & colitis.
O. Stüve,
V. Pradhan,
F. Cataldi,
2017,
Journal of Neuroimmunology.
Steven W. Martin,
G. D'Haens,
S. Nayak,
2021,
Inflammatory bowel diseases.
S. Vermeire,
J. S. Kim,
W. Sandborn,
2015
.
V. Garg,
Honghua H. Jiang,
D. Dale,
2020,
Blood.
S. Vermeire,
R. Ransohoff,
R. Clare,
2017,
Journal of Crohn's & colitis.
J. Kahn,
J. Lifson,
A. Bostrom,
1994,
Antimicrobial Agents and Chemotherapy.
G. Bernard,
J. Vincent,
J. Parrillo,
2013,
Critical care medicine.
Shanrong Zhao,
Baohong Zhang,
D. Ziemek,
2019,
Journal of Crohn's & Colitis.
S. Vermeire,
J. S. Kim,
R. Clare,
2017,
The Lancet.
J. Lifson,
A. Bostrom,
K. Gorelick,
2013
.
Jerome J. Schentag,
G. Bernard,
R. Greenman,
1991
.
T. Hibi,
R. Clare,
M. Saruta,
2020,
Intestinal research.
C. Sprung,
C. Mecher,
H. Feldman,
1991,
The New England journal of medicine.
R. Koster,
K. Gorelick,
2011,
JAMA.
K. Gorelick,
1989
.
K. Gorelick,
1989
.
K. Gorelick,
1989
.
K. E. Schwartz,
M. Petri,
V. Strand,
2002,
Arthritis and rheumatism.
K. Gorelick,
V. Byers,
1997
.
K. Gorelick,
1987
.
J. Hannigan,
P. Scannon,
N. Wedel,
1990
.
W. Reinisch,
J. Claus,
A. Banerjee,
2015
.
937 Phase I trial of GL331, a novel topoisomerase-II (T-II) inhibitor for advanced refractory cancer
F. Fossella,
R. Newman,
K. Gorelick,
1995
.
R. Greenberg,
W. S. Harkonen,
K. M. Wilson,
1988
.
N. Wedel,
K. M. Wilson,
K. Gorelick,
1992,
Critical care medicine.
K. Gorelick,
2011,
JAMA.
K. Gorelick,
2005
.
Steven W. Martin,
R. Clare,
Baohong Zhang,
2017,
Journal of Crohn's & colitis.
M. A. Martin,
R. Wenzel,
K. Gorelick,
1991,
Progress in clinical and biological research.